WTB RSS
02-25-2011, 04:29 AM
Big pharma is in big trouble, with looming patent expirations and drug generic competition weighing on health care stocks. While many health care companies are still soundly profitable,http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/0/di (http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/0/da)
http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/1/di (http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/5bxP_f4PGJg
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/5bxP_f4PGJg/7-health-care-stocks-to-sell.aspx)
http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/1/di (http://feedads.g.doubleclick.net/~a/BkbABjgmsy9Mwlem_UeJvzwtKPg/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/5bxP_f4PGJg
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/5bxP_f4PGJg/7-health-care-stocks-to-sell.aspx)